| (Values in U.S. Thousands) | Dec, 2021 | Dec, 2020 | Dec, 2019 | Dec, 2018 | Dec, 2025 |
| Sales | 720 | 690 | 270 | 0 | 0 |
| Sales Growth | +4.35% | +155.55% | unch | unch | unch |
| Net Income | -31,940 | -30,500 | -30,330 | -10 | 0 |
| Net Income Growth | -4.72% | -0.56% | -303,230.32% | unch | unch |
4D Pharma Plc ADR (LBPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
4D pharma plc is a pharmaceutical company. It involved in the development of Live Biotherapeutic products a novel class of drug derived from the microbiome. 4D pharma plc, formerly known as Longevity Acquisition Corporation, is based in NEW YORK.
Fiscal Year End Date: 12/31